Search the Archive

Medicine: Obesity Drug #369130

CBS Evening News for Monday, Apr 29, 1996
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Dan Rather) Reports introduced.

(New York: Jacqueline Adams) FDA (Food and Drug Administration) approval of a new drug called Dexfenfluramine for the treatment of obesity examined. [Representative Sam GEJDENSON - praises the new drug.] [Clinical investigators Dr. Richard WURTMAN, Dr. Charles LUCAS, John Hopkins University Dr. Mark MOLLIVER - comment on the drug.]

(Studio; Dan Rather) Report introduced.

(New York: Ray Brady) The millions being made by Interneuron Pharmaceuticals from their new diet drug examined. [Analyst David SAKS - says profits from the drug trade are greater than from any other sector.] [Pharmacologist Marcus REINDEBERG - comments.]

Adams, Jacqueline;
Brady, Ray;
Rather, Dan

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.